History
  • No items yet
midpage
291 F.R.D. 13
D. Mass.
2013
Read the full case

Background

  • Forest marketed Celexa and Lexapro; alleged off-label promotion for minors 2001–2005; FDA approved only for adults (Celexa pediatric denial).
  • MDL consolidated pretrial proceedings across Jaeckal, Palumbo, and Wilcox actions; several related actions dismissed or amended.
  • Plaintiffs seek class actions: Celexa class (under-18 use) and Lexapro class (under-18 use) across states; Wilcox seeks California UCL and FAL certification.
  • Choice-of-law analysis required Missouri home-state law for Jaeckal and Palumbo, New York law for Palumbo; California law later applied to Wilcox claims.
  • Court denied class certification for both Jaeckal/Palumbo and Wilcox; determined lack of predominance or superiority under Rule 23 in various contexts.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Choice of law governs class treatment Jaeckal/Palumbo: Missouri law; home-state protections apply Forest: applicable home-state law; conflicts render class infeasible Home-state law applies; Missouri/New York analyses favor home-state law
Class certification viability (Jaeckal/Palumbo) Common questions predominate; consumer-protection claims fit class State-law variation defeats common proof; nationwide class unmanageable Rule 23(b)(3) not satisfied; certification denied
Class certification viability (Wilcox) California UCL/FAL claims meet predominance with common misrepresentation impact Individualized exposure and deception issues prevent common proof Predominance not shown; certification denied

Key Cases Cited

  • Klaxon Co. v. Stentor Elec. Mfg. Co., 313 U.S. 487 (U.S. 1941) (forum-state choice-of-law rules govern diversity actions)
  • In re Grand Theft Auto Video Game Consumer Litig., 251 F.R.D. 139 (S.D.N.Y.2008) (multidistrict transfer choice of law considerations)
  • Goede v. Aerojet Gen. Corp., 143 S.W.3d 14 (Mo.Ct.App.2004) (Restatement §148/§6 factors for significant relationship)
  • S. States Police Benev. Ass’n, Inc. v. First Choice Armor & Equip., Inc., 241 F.R.D. 85 (D. Mass.2007) (home-state consumer protection law preferred for harm to consumers)
  • Davis-Miller v. Auto. Club of S. California, 201 Cal.App.4th 106 (Cal.App.2011) (denies class for misrepresentation claims requiring individual proof)
  • Padula v. Lilarn Props. Corp., 84 N.Y.2d 519 (N.Y.1994) (interest analysis for choice of law in New York)
Read the full case

Case Details

Case Name: In re Celexa & Lexapro Marketing & Sales Practices Litigation
Court Name: District Court, D. Massachusetts
Date Published: Feb 5, 2013
Citations: 291 F.R.D. 13; 2013 WL 450148; 2013 U.S. Dist. LEXIS 15419; MDL No. 09-02067-NMG
Docket Number: MDL No. 09-02067-NMG
Court Abbreviation: D. Mass.
Log In
    In re Celexa & Lexapro Marketing & Sales Practices Litigation, 291 F.R.D. 13